# FDA recall D-205-2013

> **Watson Laboratories Inc** · Class II · drug recall initiated 2013-02-13.

## Product

ZARAH¿ Drospirenone/ Ethinyl Estradiol Tablets, 3.0 mg/0.03 mg, Rx only, 3 tablet dispensers, 28 tablets each, Manuf. by: Watson Laboratories, Inc., Corona, CA 92880. USA; Distributed by: Watson Pharma, Inc., Corona, CA 92880 USA. NDC 52544-981-31 Carton;  NDC 52544-981-28

## Reason for recall

Failed Tablet/Capsule Specification; tablet breakage while pushing through the blister pack (dispenser) .

## Distribution

Nationwide

## Key facts

- **Recall number:** D-205-2013
- **Recalling firm:** Watson Laboratories Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-02-13
- **Report date:** 2013-03-27
- **Termination date:** 2014-01-31

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Corona, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-205-2013

## Citation

> AI Analytics. FDA recall D-205-2013. Retrieved 2026-08-01 from https://api.ai-analytics.org/recall/D-205-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*